These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 36256645
1. Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. Chow YP, Zainul Abidin N, Kow KS, Tho LM, Wong CL. PLoS One; 2022; 17(10):e0276161. PubMed ID: 36256645 [Abstract] [Full Text] [Related]
3. Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer. Roosan MR, Mambetsariev I, Pharaon R, Fricke J, Husain H, Reckamp KL, Koczywas M, Massarelli E, Bild AH, Salgia R. Chest; 2021 Sep; 160(3):1095-1107. PubMed ID: 33878340 [Abstract] [Full Text] [Related]
4. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Aggarwal A, Sharma S, Brar Z, Kumar V, Kumar A, Katara R, Mohanty SK. Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714 [Abstract] [Full Text] [Related]
5. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1. Liu J, Liu Y. Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773 [Abstract] [Full Text] [Related]
12. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms]. Li Y, Zhang FS, Guo L, Ying JM. Zhonghua Bing Li Xue Za Zhi; 2018 Dec 08; 47(12):904-909. PubMed ID: 30522169 [Abstract] [Full Text] [Related]
13. Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel. Ryan DJ, Toomey S, Smyth R, Madden SF, Workman J, Cummins R, Sheehan K, Fay J, Naidoo J, Breathnach OS, Morris PG, Grogan L, O'Brien ME, Sulaiman I, Hennessy BT, Morgan RK. Lung Cancer; 2022 Jun 08; 168():67-73. PubMed ID: 35526313 [Abstract] [Full Text] [Related]
18. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Xu X, Huang F, Cao M, Chen X, Wang H, Jiang H, Yu Y, Shen M, Yang Y, Wang B, Liu T, Guo W. J Clin Lab Anal; 2021 Sep 08; 35(9):e23818. PubMed ID: 34403504 [Abstract] [Full Text] [Related]
19. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002. Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ, BioCAST/IFCT-1002 investigators. Clin Cancer Res; 2014 Sep 01; 20(17):4613-24. PubMed ID: 25013125 [Abstract] [Full Text] [Related]